EXPLORING EFFICIENCY OF LIVING SYSTEMATIC LITERATURE REVIEW (SLR) TOOL FOR SUBMISSIONS OF CLINICAL EVIDENCE TO NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) BY COMBINING INTERVENTIONAL AND REAL-WORLD EVIDENCE (RWE)

被引:0
|
作者
Liu, R. [1 ]
Agranat, J. [2 ]
Rizzo, M. [3 ]
Forsythe, A. [4 ]
机构
[1] Cytel Inc, Toronto, ON, Canada
[2] Cytel Inc, Vaughan, ON, Canada
[3] Cytel, London, England
[4] Cytel, Waltham, MA USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
HTA158
引用
收藏
页码:S349 / S349
页数:1
相关论文
共 40 条
  • [21] USING REAL-WORLD EVIDENCE FOR HEALTH TECHNOLOGY ASSESSMENT SUBMISSIONS: LESSONS AND INSIGHTS FROM REVIEW OF NICE'S TECHNOLOGY ASSESSMENT REPORTS (2016-2017)
    Aggarwal, S.
    Topaloglu, O.
    Kumar, S.
    VALUE IN HEALTH, 2018, 21 : S7 - S7
  • [22] Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis (UC): evidence from a systematic literature review (SLR)
    Irving, P. M.
    Hur, P.
    Gautam, R.
    Guo, X.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 739 - 740
  • [23] Methodological challenges using routine clinical care data for real-world evidence: a rapid review utilizing a systematic literature search and focus group discussion
    Pfaffenlehner, Michelle
    Behrens, Max
    Zoeller, Daniela
    Ungethuem, Kathrin
    Guenther, Kai
    Ruecker, Viktoria
    Reese, Jens-Peter
    Heuschmann, Peter
    Kesselmeier, Miriam
    Remo, Flavia
    Scherag, Andre
    Binder, Harald
    Binder, Nadine
    BMC MEDICAL RESEARCH METHODOLOGY, 2025, 25 (01)
  • [24] Meta-analyses using real-world data to generate clinical and epidemiological evidence: a systematic literature review of existing recommendations
    Briere, Jean-Baptiste
    Bowrin, Kevin
    Taieb, Vanessa
    Millier, Aurelie
    Toumi, Mondher
    Coleman, Craig
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (12) : 2125 - 2130
  • [25] Impact of surgery and its complications in ulcerative colitis patients in clinical practice: A systematic literature review of real-world evidence in Europe
    Fradet, C.
    Kern, J.
    Atanasov, P.
    Wirth, D.
    Borsi, A.
    INTERNATIONAL JOURNAL OF SURGERY OPEN, 2020, 22 : 22 - 32
  • [26] IMPACT OF DE NOVO REAL-WORLD EVIDENCE (RWE) GENERATION IN HEALTH TECHNOLOGY ASSESSMENT (HTA): CASE STUDY OF THE INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW'S (ICER) SICKLE CELL DISEASE (SCD) ASSESSMENT
    Jaksa, A.
    Bradt, P.
    Patrick, A.
    Schneeweiss, S.
    Spackman, E.
    VALUE IN HEALTH, 2020, 23 : S708 - S708
  • [27] LEVERAGING REAL-WORLD EVIDENCE TO EXTEND DRUGDRUG INTERACTION ASSESSMENT FROM DRUG DEVELOPMENT TO CLINICAL CARE: A TARGETED REVIEW OF THE LITERATURE
    Quignot, N.
    Shigesi, N.
    Kikuchi, K.
    Argon, S.
    Ragueneau-Majlessi, I
    VALUE IN HEALTH, 2024, 27 (12) : S602 - S602
  • [28] Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence
    Brown, Darron R.
    Joura, Elmar A.
    Yen, Glorian P.
    Kothari, Smita
    Luxembourg, Alain
    Saah, Alfred
    Walia, Anuj
    Perez, Gonzalo
    Khoury, Hanane
    Badgley, Danielle
    Stanley, Margaret
    VACCINE, 2021, 39 (16) : 2224 - 2236
  • [29] Axitinib after Treatment Failure with Sunitinib or Cytokines in Advanced Renal Cell Carcinoma-Systematic Literature Review of Clinical and Real-World Evidence
    Sharma, Anand
    Bahl, Amit
    Frazer, Ricky
    Godhania, Esha
    Halfpenny, Nicholas
    Hartl, Kristina
    Heldt, Dorothea
    McGrane, John
    Guelser, Sera Sahbaz
    Venugopal, Balaji
    Ritchie, Aimi
    Crichton, Katherine
    CANCERS, 2024, 16 (15)
  • [30] Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review
    Briere, Jean-Baptiste
    Bowrin, Kevin
    Coleman, Craig
    Fauchier, Laurent
    Levy, Pierre
    Folkerts, Kerstin
    Toumi, Mondher
    Taieb, Vanessa
    Millier, Aurelie
    Wu, Olivia
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (01) : 27 - 36